All Curated Mutation Sites in HPV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All

E1^E4

Keyword: Uterine Cervical Diseases-31138240

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	31138240	A388C	E7	E7	Uterine Cervical Diseases	G S C L	View
2	31138240	C367A	E7	E7	Uterine Cervical Diseases	G S C L	View
3	31138240	D76E	E7	E7	Uterine Cervical Diseases	G S C L	View
4	31138240	G203C	E7	E7	Uterine Cervical Diseases	G S C L	View
5	31138240	G41R	E7	E7	Uterine Cervical Diseases	G S C L	View
6	31138240	G543A	E7	E7	Uterine Cervical Diseases	G S C L	View
7	31138240	G63D	E7	E7	Uterine Cervical Diseases	G S C L	View
8	31138240	G63S	E7	E7	Uterine Cervical Diseases	G S C L	View
9	31138240	R9K	E7	E7	Uterine Cervical Diseases	G S C L	View
10	31138240	T20I	E7	E7	Uterine Cervical Diseases	G S C L	View
11	31138240	T61N	E7	E7	Uterine Cervical Diseases	G S C L	View
12	31138240	T64A	E7	E7	Uterine Cervical Diseases	G S C L	View
13	31138240	T74A	E7	E7	Uterine Cervical Diseases	G S C L	View
14	31138240	V77A	E7	E7	Uterine Cervical Diseases	G S C L	View
15	31138240	A763G	E6	E6	Uterine Cervical Diseases	G S C L	View
16	31138240	A793G	E6	E6	Uterine Cervical Diseases	G S C L	View
17	31138240	C632T	E6	E6	Uterine Cervical Diseases	G S C L	View
18	31138240	C755A	E6	E6	Uterine Cervical Diseases	G S C L	View
19	31138240	C801A	E6	E6	Uterine Cervical Diseases	G S C L	View
20	31138240	D86E	E6	E6	Uterine Cervical Diseases	G S C L	View
21	31138240	E32Q	E6	E6	Uterine Cervical Diseases	G S C L	View
22	31138240	G599A	E6	E6	Uterine Cervical Diseases	G S C L	View
23	31138240	G694A	E6	E6	Uterine Cervical Diseases	G S C L	View
24	31138240	G760A	E6	E6	Uterine Cervical Diseases	G S C L	View
25	31138240	G761A	E6	E6	Uterine Cervical Diseases	G S C L	View
26	31138240	R145K	E6	E6	Uterine Cervical Diseases	G S C L	View
27	31138240	T803C	E6	E6	Uterine Cervical Diseases	G S C L	View
28	31138240	A45E	E7	E7	Uterine Cervical Diseases	G R S C L	View
29	31138240	A45V	E7	E7	Uterine Cervical Diseases	G R S C L	View
30	31138240	A862T	E7	E7	Uterine Cervical Diseases	G R S C L	View
31	31138240	C706A	E7	E7	Uterine Cervical Diseases	G R S C L	View
32	31138240	C706T	E7	E7	Uterine Cervical Diseases	G R S C L	View
33	31138240	G658C	E7	E7	Uterine Cervical Diseases	G R S C L	View
34	31138240	Q97L	E7	E7	Uterine Cervical Diseases	G R S C L	View
35	31138240	S29T	E7	E7	Uterine Cervical Diseases	G R S C L	View
36	31138240	S29 T	E7	E7	Uterine Cervical Diseases	G R S C L	View
37	31138240	A213C	E6	E6	Uterine Cervical Diseases	G R S C L	View
38	31138240	A364C	E6	E6	Uterine Cervical Diseases	G R S C L	View
39	31138240	A387C	E6	E6	Uterine Cervical Diseases	G R S C L	View
40	31138240	A446G	E6	E6	Uterine Cervical Diseases	G R S C L	View
41	31138240	G329C	E6	E6	Uterine Cervical Diseases	G R S C L	View
42	31138240	G542T	E6	E6	Uterine Cervical Diseases	G R S C L	View
43	31138240	K35N	E6	E6	Uterine Cervical Diseases	G R S C L	View
44	31138240	K35 N	E6	E6	Uterine Cervical Diseases	G R S C L	View
45	31138240	K93N	E6	E6	Uterine Cervical Diseases	G R S C L	View
46	31138240	K93 N	E6	E6	Uterine Cervical Diseases	G R S C L	View
47	31138240	N86H	E6	E6	Uterine Cervical Diseases	G R S C L	View
48	31138240	Q113R	E6	E6	Uterine Cervical Diseases	G R S C L	View
49	31138240	R145I	E6	E6	Uterine Cervical Diseases	G R S C L	View
50	31138240	S74T	E6	E6	Uterine Cervical Diseases	G R S C L	View
51	31138240	S74 T	E6	E6	Uterine Cervical Diseases	G R S C L	View

Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.